Company intelligence / Profile preview

ProStrakan

Galashiels, Scotland, United Kingdomprostrakan.com ↗

Ownership: Private
Development stage: Commercial

Overview

ProStrakan was a Scotland-based specialty pharmaceutical company engaged in developing and commercializing prescription medicines for unmet medical needs across Europe and the US. It was acquired by Japan’s Kyowa Hakko Kirin Co., Ltd. in 2011. In April 2016, it rebranded as Kyowa Kirin International plc to unify global operations under the parent company's name. The business remains active under this new identity with a focus on launching near-to-market products.

Therapeutic areas: Other
Modalities: Small moleculesBiologics/therapeutic antibodies (via parent company capabilities)
Industry: Biotech

Drug pipeline

3 assets

neostigmine methylsulfate

Commercial

Indications: Reversal of neuromuscular blocking agents

2 more assets in the full pipeline.

Request access →

Partnerships

Previously collaborated with Novartis (bone) and Amgen (renal), NovaQuest Alliance for US sales force expansion.

Beyond the preview

Go deeper on ProStrakan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProStrakan.

Explore the full profile